← All trials
NCT05611853
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 25, 2022
- Primary completion
- Dec 30, 2023
- Completion date
- Dec 30, 2024
- First posted
- Nov 10, 2022
- Last posted
- Nov 10, 2022
- Enrollment
- 50
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BioNova Pharmaceuticals (Shanghai) LTD.Lead sponsor
- Henan Medical UniversityOverall official - principal investigator
- Jiao Tong UniversityOverall official - principal investigator
- Soochow UniversityOverall official - principal investigator
- Huazhong University of Science and TechnologyOverall official - principal investigator
- Jiao Tong UniversityOfficial
- Soochow UniversityOfficial
- Huazhong University of Science and TechnologyOfficial
- Henan Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.